Clinical studies have shown that GLP-1 medications may help support metabolic health during the menopause transition by improving metabolic stability and supporting blood sugar control
Therefore, although DPP-4 inhibition reduces both fasting and postprandial glucose and HbA 1c levels, the effects are weaker than for GLP-1 receptor agonists, and they do not exhibit a body weight reduction effect, although they are body weight neutral
Saxenda is not for treating type 1 or type 2 diabetes and is not is not a weight-loss medicine or appetite suppressant (Drugs.com)
You may experience a loss of appetite, nausea, vomiting, and diarrhea, but these effects usually fade as you use the medication more
The pharmacy prepares your medication, packages it, and ships it directly to your address
Patient reported data suggest that mild to moderate nausea and related symptoms often begin to settle over 28 weeks, with further improvement over several months for many but not all patients